Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / Ordinary Shares, par value $0.0001 per share
-
Shares outstanding
-
134M
-
Number of holders
-
29
-
Total 13F shares, excl. options
-
12.1M
-
Shares change
-
+3.32M
-
Total reported value, excl. options
-
$64.4M
-
Value change
-
+$17.8M
-
Put/Call ratio
-
9.89
-
Number of buys
-
15
-
Number of sells
-
-17
-
Price
-
$5.34
Significant Holders of Global Cord Blood Corp - Ordinary Shares, par value $0.0001 per share (CORBF) as of Q2 2021
41 filings reported holding CORBF - Global Cord Blood Corp - Ordinary Shares, par value $0.0001 per share as of Q2 2021.
Global Cord Blood Corp - Ordinary Shares, par value $0.0001 per share (CORBF) has 29 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 12.1M shares
of 134M outstanding shares and own 9.02% of the company stock.
Largest 10 shareholders include RENAISSANCE TECHNOLOGIES LLC (3.36M shares), BlueCrest Capital Management Ltd (3.2M shares), Oasis Management Co Ltd. (2.18M shares), Man Group plc (1.76M shares), Quinn Opportunity Partners LLC (324K shares), BARCLAYS PLC (181K shares), Qube Research & Technologies Ltd (179K shares), NATIXIS ADVISORS, L.P. (171K shares), ARROWSTREET CAPITAL, LIMITED PARTNERSHIP (147K shares), and SG Americas Securities, LLC (127K shares).
This table shows the top 29 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.